The Goldman Sachs Group Trims DENTSPLY SIRONA (NASDAQ:XRAY) Target Price to $30.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target lowered by The Goldman Sachs Group from $34.00 to $30.00 in a report issued on Monday morning, Benzinga reports. The brokerage currently has a neutral rating on the medical instruments supplier’s stock.

Several other brokerages have also commented on XRAY. Evercore ISI cut their target price on DENTSPLY SIRONA from $40.00 to $35.00 and set an outperform rating on the stock in a research report on Friday, May 3rd. SVB Leerink began coverage on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. They set an outperform rating and a $42.00 price objective for the company. Leerink Partnrs reiterated an outperform rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Robert W. Baird cut their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating on the stock in a research note on Friday, May 3rd. Finally, Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $41.00 to $38.00 and set an outperform rating for the company in a research note on Friday, May 3rd. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of Moderate Buy and an average price target of $35.22.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $27.81 on Monday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. DENTSPLY SIRONA has a one year low of $26.27 and a one year high of $41.65. The business’s 50 day simple moving average is $31.80 and its 200 day simple moving average is $32.63. The stock has a market capitalization of $5.77 billion, a PE ratio of -63.20, a PEG ratio of 1.24 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same period in the prior year, the firm posted $0.39 EPS. The company’s quarterly revenue was down 2.6% on a year-over-year basis. As a group, research analysts forecast that DENTSPLY SIRONA will post 2.03 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Wednesday, March 27th. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a dividend yield of 2.30%. DENTSPLY SIRONA’s payout ratio is presently -145.45%.

Hedge Funds Weigh In On DENTSPLY SIRONA

Hedge funds have recently added to or reduced their stakes in the stock. VisionPoint Advisory Group LLC raised its stake in shares of DENTSPLY SIRONA by 104.2% in the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 395 shares during the last quarter. Principal Securities Inc. bought a new position in DENTSPLY SIRONA during the 4th quarter valued at $26,000. Headlands Technologies LLC bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth $30,000. Parkside Financial Bank & Trust raised its holdings in shares of DENTSPLY SIRONA by 33.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 292 shares during the last quarter. Finally, Anchor Investment Management LLC bought a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at about $47,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.